Assignee
CYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD
HU·3 granted patents·4 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
7 records- 0168USRE50534ECyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseasesCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2023·Granted Aug 19, 2025·0 cites·4 claims
- 0264US11446325B2Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseasesCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2020·Granted Sep 20, 2022·0 cites·4 claims
- 0357US2023346825A1Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseasesCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2021·Application pending·0 cites
- 0453US11649299B2Purification of sulfobutylated cyclodextrins with specific ion exchange resinsCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2021·Granted May 16, 2023·0 cites·8 claims
- 0549US2022282001A1Stabilization of proteins with cyclodextrinsCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2021·Application pending·0 cites
- 0647US2022152087A1Cyclodextrin derivatives reducing flavivirus ns1-induced endothelial hyperpermeability and vascular leakCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2020·Application pending·0 cites
- 0747US2021145816A1Pharmaceutical formulation of lonafarnib with a sulfobutylether beta-cyclodextrinCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →